Skip to Main Content

News Center

MCART

CERSI Conference Spotlights Need for Mass Spectrometry in Drug Development

April 16, 2014

Researchers from academia, government, and industry examine current challenges surrounding mass spectrometry as a drug development tool, including its status of adoption by industry and potential regulatory implications.

SOP Joins International Group to Advance Treatments for Radiation Injuries

January 31, 2013

The Mass Spectrometry facility at the University of Maryland School of Pharmacy will lead investigation to identify and characterize new biomarkers of radiation damage.